Cap-dependent endonuclease-IN-10
Modify Date: 2025-08-24 22:28:03
Cap-dependent endonuclease-IN-10 structure
|
Common Name | Cap-dependent endonuclease-IN-10 | ||
|---|---|---|---|---|
| CAS Number | 2663989-04-4 | Molecular Weight | 524.50 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C25H18F2N4O5S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Cap-dependent endonuclease-IN-10Cap-dependent endonuclease-IN-10 is a potent inhibitor of cap-dependent endonuclease (CEN). Not only can Cap-dependent endonuclease-IN-10 inhibit influenza virus well, but also has lower cytotoxicity, better in vivo pharmacokinetic and in vivo pharmacodynamic properties, and better hepatic microsomal stability. Cap-dependent endonuclease-IN-10 has the potential for the research of viral infections (including influenza A, influenza B and influenza C) (extracted from patent WO2021129799A1, compound 1-1)[1]. |
| Name | Cap-dependent endonuclease-IN-10 |
|---|
| Description | Cap-dependent endonuclease-IN-10 is a potent inhibitor of cap-dependent endonuclease (CEN). Not only can Cap-dependent endonuclease-IN-10 inhibit influenza virus well, but also has lower cytotoxicity, better in vivo pharmacokinetic and in vivo pharmacodynamic properties, and better hepatic microsomal stability. Cap-dependent endonuclease-IN-10 has the potential for the research of viral infections (including influenza A, influenza B and influenza C) (extracted from patent WO2021129799A1, compound 1-1)[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Yingjun Zhang, et al. Influenza virus replication inhibitors and their uses. Patent WO2021129799A1. |
| Molecular Formula | C25H18F2N4O5S |
|---|---|
| Molecular Weight | 524.50 |